MedTrace Logo

CP1110 Sound Processor Feasibility

NCT04898673 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2025-02-11

Study results available
· View outcomes & findings →

Summary

The clinical study aims to investigate the speech performance with the CP1110 Sound Processor, compared with the CP1000 Sound Processor, and inclusion of a noise reduction feature in the Automatic Scene Classifier..

Conditions

  • Adult Cochlear Implant Recipients

Interventions

DEVICE

CP1110

Sound Processor

DEVICE

CP1000

Sound Processor

Sponsors & Collaborators

  • Avania

    collaborator INDUSTRY

  • Cochlear

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-25
Primary Completion
2021-12-16
Completion
2021-12-16

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04898673 on ClinicalTrials.gov